Longevity Investors Conference: Gstaad at the centre of a global conversation

The sixth edition of the Longevity Investors Conference (LIC 2025) has just wrapped up at Le Grand Bellevue, once again placing Gstaad at the crossroads of science, capital and innovation. Over four days, a carefully selected group of researchers, entrepreneurs and investors discussed the future of ageing — and how we might not just live longer, but live better.

From buzzword to serious science
Longevity has matured into a recognised field that unites cutting-edge research with investment strategies. At LIC 2025, the message was clear: ageing science is advancing rapidly, and with it, the need for new ideas, new funding models, and practical applications. “The longevity sector is rapidly emerging as one of the most compelling investment themes of our time … now is the perfect moment to raise awareness and equip investors with the knowledge to engage in this transformative space,” said co-founder Dr. Tobias Reichmuth.

The big themes in Gstaad
According to the organisers’ summary, five themes dominated this year’s programme:

• AI and automation are now integral components of longevity research. “Scientific discoveries and technological breakthroughs allow us to reverse ageing and treat age-related diseases. It’s important to support this brave, world-changing idea with capital,” explained Sergey Young, founding partner of the BOLD Longevity Growth Fund.
   
• Women’s health span is no longer a side issue. Demographic, economic and clinical arguments came together to highlight the urgent need for targeted innovation. “LIC creates that mix and does it in an intimate way where connections become personal,” noted scientist Dr. Matt Kaeberlein, praising the exchange of ideas.
   
• From science to practice: speakers urged honesty about what is ready today and what remains on the horizon. “We had some of the most revealing conversations I’ve ever had — honest, curious, and wide open,” said Dr. Jamie Justice, Executive Director of XPRIZE Healthspan.
   
• Investment strategies are becoming increasingly sophisticated, with family offices and funds being urged to engage more deeply and consider both access and returns.
   
• Cross-sector collaboration featured strongly, with talks on cryopreservation, blood purification and translational science highlighting how progress in longevity depends on combining expertise..

The Gstaad setting
For many participants, the Alpine setting provided a unique backdrop. Breaks in the programme included guided walks in the mountains, tastings of local specialities and cultural encounters. Co-founder Marc P. Bernegger reflected: “Our mission is to not just host a conference, but to build a trusted global hub where serious investors and visionary scientists can meet, challenge each other, and together accelerate the future of human health span.”

He also shared feedback from speakers: “Many of our guests are professors or researchers who hardly ever leave their institutes. To speak here, surrounded by mountains and fresh air, was a fantastic change for them.”

Looking ahead
With global longevity investments projected to surpass USD 600 billion by 2026, the organisers confirmed that Longevity Investors will expand beyond the annual Gstaad gathering with year-round initiatives designed to support continued dialogue and collaboration.

For readers of GstaadLife, this is just the beginning. In our upcoming winter issues, we will delve deeper into the world of longevity, exploring the science, start-ups, and what this evolving field could mean for our everyday lives.

— Jeanette Wichmann